ReproCELL Incorporated (TYO:4978)
Japan · Delayed Price · Currency is JPY 127.00
+4.00 (3.25%)
Jun 3, 2026, 3:30 PM JST
ReproCELL Market Cap
ReproCELL has a market cap or net worth of 11.69 billion as of June 2, 2026. Its market cap has decreased by -11.83% in one year.
Market Cap
11.69B
Enterprise Value
5.18B
Revenue
2.23B
Ranking
n/a
PE Ratio
n/a
Stock Price
127.00
Market Cap Chart
Since June 27, 2013, ReproCELL's market cap has decreased from 145.35B to 11.69B, a decrease of -91.96%. That is a compound annual growth rate of -17.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 11.69B | -11.82% |
| Dec 30, 2025 | 13.26B | 35.27% |
| Dec 30, 2024 | 9.80B | -34.19% |
| Dec 29, 2023 | 14.89B | -42.13% |
| Dec 30, 2022 | 25.73B | 35.26% |
| Dec 30, 2021 | 19.02B | -35.21% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| StemRIM | 18.55B |
| Renascience | 18.25B |
| RaQualia Pharma | 13.04B |
| Stella Pharma | 11.88B |
| CanBas | 11.68B |
| Immuno-Biological Laboratories | 10.05B |
| Nano Holdings | 9.77B |
| CellSeed | 9.66B |